Tests and Normal Values in Pediatric Endocrinology

Clinical Pediatric Endocrinology: Fifth Edition

Volumn , Issue , 2007, Pages 523-564

  Tetlow, Lesley J ^a   Clayton, Peter E ^b  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Corticotrophin releasing hormone (CRH) test; Endocrine tests; Growth hormone deficiency; Insulin tolerance test; Pediatric endocrinology

Indexed keywords

EID: 84889482623     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470987117.ch25     Document Type: Chapter

References (84)

1. Klee G. Maximising efficacy of endocrine tests: importance of decision-focused testing strategies and appropriate patient preparation. Clin Chem 1999; 45: 1323-30.
2. Barth JH, Butler GE, Hammond P. Safety considerations during endocrine/metabolic tests in children. Biochemical Investigations in Laboratory Medicine. Hooper J, Sherwood R, Marshall W, eds. Tunbridge Wells ACB Venture Publications, 2001: 2.
3. Shah A, Stanhope R, Matthew D. Hazards of pharmacological tests of growth hormone secretion in childhood. BMJ 1992; 304: 173-4.
4. Drake WM, Trainer PJ. Pituitary assessment strategy. In: Wass JA, Shalet SM, eds. Oxford Textbook of Endocrinology and Diabetes. New York: Oxford University Press, 2002: 127-36.
5. Shalet SM, Toogood A, Rahim A, Brennan BMD. The diagnosis of growth hormone deficiency in children and adults. Endocr Rev 1998; 19: 203-23.
6. GH Research Society. Consensus guidelines for the diagnosis and treatment of GH deficiency in childhood and adolescence: summary statement of the GH Research Society. J Clin Endocrinol Metabol 2000; 85: 3990-3.
7. Butler J. Role of biochemical tests in assessing the need for growth hormone therapy in children with short stature: Royal College of Pathologists' Clinical Audit Project. Ann Clin Biochem 2001; 38: 1 (for full text see http://www.leeds.ac.uk/acb/annals).
8. Clayton PE. Investigation of the poorly growing child. In: Wass JA, Shalet SM, eds. Oxford Textbook of Endocrinology and Diabetes. New York: Oxford University Press, 2002: 1001-8.
9. Bristow AF. International standards for growth hormone. Horm Res 1999; 51 (Suppl. 1): 7-12.
10. Seth J, Ellis A, Al-Sadie R. Serum growth hormone measurements in clinical practice: an audit of performance from the UK National External Quality Assessment Scheme. Horm Res 1999; 51 (Suppl. 1): 13-19.
11. National Institute for Clinical Excellence. Guidance on the use of human growth hormone (somatotropin) in children with growth failure. Technol Appraisal Guidance 2002; 42.
12. Orme SM. Peacey SR, Barth JH, Belchetz PE. Comparison of tests of stress-released cortisol secretion in pituitary disease. Clin Endocrinol (Oxf) 1996; 45: 135-40.
13. Ghigo E, Bartolotta E, Imperiale E et al. Glucagon stimulates GH secretion after intramuscular but not intravenous administration. Evidence against the assumption that glucagon per se has a GH releasing activity. J Endocrinol Invest 1994; 17: 849-54.
14. Littley MD, Gibson S, White A, Shalet SM. Comparison of the ACTH and cortisol responses to provocative testing with glucagons and insulin hypoglycaemia in normal subjects. Clin Endocrinol 1989; 31: 527-33.
15. Ranke MB, Haber P. Growth hormone stimulation tests. In: Ranke MB, ed. Diagnostics of Endocrine Function in Children and Adolescents. Heidelberg: Johann Ambrosius Barth, 1996: 134-48.
16. Zadik Z, Chale SA, Kowarski A. Assessment of growth hormone secretion in normal stature children using 24-hour integrated concentration of GH and pharmacological stimulation. J Clin Endocrinol Metab 1990; 71: 932-6.
17. Aimaretti G, Baffoni C, DiVito L et al. Comparisons among old and new provocative tests of GH secretion in 178 normal adults. Eur J Endocrinol 2000; 142: 347-52.
18. Clayton PE. The role of insulin-like factors in the diagnosis of growth hormone deficiency. In: Ranke MB, Wilton P, eds. Growth Hormone Therapy in KIGS: Ten years' experience 1987-1997. Mannheim: Edition J and J, 1999: 53-64.
19. Rosenfield RG, Rosenbloom AL, Guevara-Aguirre J. Growth hormone insensitivity due to primary GH receptor deficiency. Endocr Rev 1994; 15: 369-90.
20. Mullis PE. Tall stature. In: Wass JA, Shalet SM, eds. Oxford Textbook of Endocrinology and Diabetes. New York: Oxford University Press, 2002: 10029-33.
21. Melmed S, Ho K, Klibanski A, Reichlin S, Thorner M. Recent advances in pathogenesis, diagnosis and management of acromegaly. J Clin Endocrinol Metab 1995; 80: 3395-402.
22. Tan SL. Hyperprolactinaemia and the management of related tumours. Curr Opin Obstet Gynaecol 1990; 2: 378-85.
23. Olukoga AO, Kane JW. Macroprolactinaemia: validation and application of the polyethylene glycol precipitation test and clinical characterisation of the condition. Clin Endocrinol 1999; 51: 119-26.
24. Olukoga AO, Kane JW. Screening for macroprolactinaemia. Ann Clin Biochem 1997; 34: 701-3.
25. Hermus ARMM, Pieters GFF, Pesman GJ, Smals AGH, Benraad TJ, Kloppenborg PWC. ACTH and cortisol responses to ovine corticotrophin-releasing factor in patients with primary and secondary adrenal failure. Clin Endocrinol 1985; 22: 761-9.
26. Perry LA, Grossman AB. The role of the laboratory in the diagnosis of Cushing syndrome. Ann Clin Biochem 199; 34: 345-59.
27. Oldfield EH, Doppman JL, Nieman LK et al. Petrosal sinus sampling with and without corticotrophin releasing hormone for the differential diagnosis of Cushing syndrome. N Engl J Med 1991; 325: 897-905.
28. Penney M. Sodium, water and potassium. In: Marshall WJ, Bangert SK, eds. Clinical Biochemistry. London: Churchill Livingstone, 1995: 25-60.
29. Mohn A, Acerini C, Cheetham T, Lightman S, Dunger D. Hypertonic saline infusion test for the investigation of posterior pituitary function. Arch Dis Child 1998; 79: 431-4.
30. Oelkers W. Adrenal insufficiency. N Engl J Med 1996; 335: 1206-12.
31. Parker KL, Kovacs WJ. Addison's disease (adrenal insufficiency). In: Wass JA, Shalet SM, eds. Oxford Textbook of Endocrinology and Diabetes. New York: Oxford University Press, 2002: 837-44.
32. Grinspoon SK, Biller BM. Laboratory assessment of adrenal insufficiency. J Clin Endocrinol Metab 1994; 79: 923-31.
33. Vermes I, Beishuizen A, Hampsink R, Haanen C. Dissociation of plasma adrenocorticotrophin concentrations in critically ill patients: possible role of endothelian and atrial natriuretic hormone. J Clin Endocrinol Metab 1995; 80: 1238-42.
34. Gleeson H, Walker B, Seckl J, Padfield P. Ten years on: safety of short synacthen tests in assessing adrenocorticotropin deficiency in clinical practice. J Clin Endocrinol Metab 2003; 88: 2106-11.
35. Wang T, Wong M. Falconer Smith J, Howlett T. The use of the short tetracosactrin test for the investigation of suspected pituitary hypofunction. Ann Clin Biochem 1996: 33: 112-18.
36. Barth J, Seth J, Howlett T, Freedman D. A survey of endocrine function testing by clinical biochemistry laboratories in the UK. Ann Clin Biochem 1995; 32: 442-9.
37. Clark P, Neylon I, Raggatt P, Sheppard M, Stewart P. Defining the normal cortisol response to the short Synacthen test: implications for the investigation of hypothalamic-pituitary disorders. Clinical Endocrinol 1998; 49: 287-92.
38. Wallace AM. Analytical support for the detection and treatment of congenital adrenal hyperplasia. Ann Clin Biochem 1995; 32: 9-27.
39. Rasmuson S, Olsson T, Hagg E. A low dose ACTH test to assess the function of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol 1996; 44: 151-6.
40. Dickstein G. Hypothalamo-pituitary-adrenal axis testing: nothing is sacred and caution in interpretation is needed. Clin Endocrinol 2001; 54: 15-16.
41. Editorial. Shortcomings in the low-dose (1 μg) ACTH test for the diagnosis of ACTH deficiency states. J Clin Endocrinol Metab 1999; 84: 835-7.
42. Peacey S, Guo C, Robinson A et al. Glucocorticoid replacement therapy: are patients over treated and does it matter? Clin Endocrinol 1997; 46: 255-61.
43. Honour J, Brook C. Clinical indications for the use of urinary steroid profiles in neonates and children. Ann Clin Biochem 1997: 34: 45-54.
44. Trainer P, Newell-Price J, Besser M. Cushing syndrome. In: Wass JA, Shalet SM, eds. Oxford Textbook of Endocrinology and Diabetes. New York: Oxford University Press, 2002: 817-29.
45. Weber A, Trainer P, Grossman A et al. Investigation, management and therapeutic outcome in 12 cases of childhood and adolescent Cushing syndrome. Clin Endocrinol 1995; 43: 19-28.
46. Magiakou M, Mastorakos G, Oldfield E et al. Cushing syndrome in children and adolescents: presentation, diagnosis and therapy. N Engl J Med 1994; 331: 629-36.
47. Grossman A, Perry L. The role of the laboratory in the diagnosis of Cushing syndrome. Ann Clin Biochem 1997: 34: 345-59.
48. Trainer P, Grossman A. The diagnosis and differential diagnosis of Cushing syndrome. Clin Endocrinol 1991; 34: 317-30.
49. Katznelson L, Bogan JS, Trob JR et al. Biochemical assessment of Cushing's disease in patients with corticotroph adenomas. J Clin Endocrinol Metab 1998; 83: 1619-23.
50. Reimondo G, Paccotti P, Minetto M et al. The corticotrophin-releasing hormone test is the most reliable non-invasive method to differentiate pituitary from ectopic secretion in Cushing syndrome. Clin Endocrinol 2003; 58: 718-24.
51. Fitzgibbon M, Tormey W. Paediatric reference ranges for urinary catecholamines/metabolites and their relevance in neuroblastoma diagnosis. Ann Clin Biochem 1994; 31: 1-11.
52. Editorial. Biochemical diagnosis of phaeochromocytoma-is it time to switch to plasma-free metanephrines? J Clin Endocrinol Metab 2003; 88: 550-2.
53. Sawka A, Jaeschke, Singh R, Young W. A comparison of biochemical tests for phaeochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab 2003; 88: 553-8.
54. Peaston R, Weinkove C. Measurement of catecholamines and their metabolites. Ann Clin Biochem 2004; 41: 17-38.
55. Tuchman M, Robison L, Maynard R, Ramnaraine M, Krivit W. Assessment of the diurnal variations in urinary homovanillic and vanillylmandelic acid excretion for the diagnosis and follow up of patients with neuroblastoma. Clin Biochem 1985; 18; 176-9.
56. Henderson M, Heney D, McGinlay J, Lewis I, Bailey C. Measurement of dopamine, HVA and HMMA in untimed urine samples: establishment of age-related reference ranges in children. Ann Clin Biochem 1992; 29: 162-7.
57. Honour J, Savage M. Testicular endocrine function. In: Ranke MB, ed. Diagnostics of Endocrine Function in Children and Adolescents. Heidelberg: Johann Ambrosius Barth, 1996: 134-48.
58. Editorial. Metabolic lessons from the study of young adolescents with polycystic ovarian syndrome. J Clin Endocrinol Metab 2000; 85: 3520-5.
59. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997; 18: 774-800.
60. Tsilchorozidou T, Overton C, Conway G. The pathophysiology of polycystic ovary syndrome. Clin Endocrinol 2004; 60: 1-17.
61. Roger M, Lahlou, Chaussain JL. Gonadotrophin-releasing hormone testing in pediatrics. In: Ranke MB, ed. Diagnostics of Endocrine Function in Children and Adolescents. Heidelberg: Johann Ambrosius Barth, 1996: 346-69.
62. Dattani M, Hindmarsh P. Premature sexual maturation. In: Wass JA, Shalet SM, eds. Oxford Textbook of Endocrinology and Diabetes. New York: Oxford University Press, 2002: 1046-55.
63. Editorial. Precocious puberty: who has it? Who should be treated? J Clin Endocrinol Metab 1999; 84: 411-14.
64. Symons R. Interference with the laboratory assessment of thyroid function. Clin Biochem Rev 1989; 10: 44-9.
65. Liewendahl K. Thyroid function tests: performance and limitations of current methodologies. Scand J Clin Lab Invest 1992; 52: 435-45.
66. Toft A. Thyroxine therapy. N Engl J Med 1994; 331: 174-9.
67. Beck-Peccoz P, Brucker-Davis F, Persani L et al. Thyrotrophin-secreting pituitary tumours. Endocr Rev 1996; 17: 610-38.
68. Sterling K, Refetoff S, Selenkow H. T3 thyrotoxicosis. Thyrotoxicosis due to elevated triiodothyronine concentrations. J Am Med Assoc 1970; 213: 571-5.
69. Hollick M. Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health. Curr Opin Endocrinol Diab 2002; 8: 87-98.
70. Lucas A, Morley R, Cole J. Adverse neurodevelopment outcome of moderate neonatal hypoglycaemia. BMJ 1988; 297: 1304-8.
71. Green A, Morgan I, Gray J. Hypo-and hyperglycaemia. In: Harris B, Marshall W, eds. Neonatology and Laboratory Medicine. Tunbridge Wells: ACB Venture Publications, 2003: 107-24.
72. Green A, Hussain K, Hall J et al. Practical management of hyper-insulinism in infancy. Arch Dis Child Fetal Neonatal Ed 2000; 82: F98-107.
73. Glaser B, Thornton P, Otonski T, Junien C. Genetics of neonatal hyperinsulinism. Arch Dis Child Fetal Neonatal Ed 2000; 82: F79-86.
74. World Health Organization, Department of Non-Communicable Disease Surveillance. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva: World Health Organization, 1999.
75. Lamb E, Day A. New diagnostic criteria for diabetes mellitus: are we any further forward? Ann Clin Biochem 2000; 37: 588-92.
76. Ehtisham S, Barrett T. The emergence of type 2 diabetes in childhood. Ann Clin Biochem 2004; 41: 10-16.
77. Yeckel C, Weiss R, Dziura et al. Validation of insulin sensitivity indices from oral glucose tolerance test parameters in obese children and adolescents. J Clin Endocrinol Metab 2004; 89: 1096-101.
78. Sacks D, Bruns D, Goldstein D, Maclaren N, McDonald J, Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2002; 48: 436-72.
79. Wallace A. Measurement of leptin and leptin binding in the human circulation. Ann Clin Biochem 2000; 37: 244-52.
80. Morelli A, Falchetti A, Brandi M. Gene mutations in multiple endocrine neoplasia type 1. Topical Endocrinol 2001; 18: 6-9.
81. Johnston L, Chew S, Trainer P et al. Screening children at risk of developing inherited endocrine neoplasia syndromes. Clin Endocrinol 2000; 52: 127-36.
82. Hoff A, Cote G, Lee J, Evans D, Gagel R. Multiple endocrine neoplasia type 2. In: Wass JA, Shalet SM, eds. Oxford Textbook of Endocrinology and Diabetes. Oxford University Press, 2002: 865-70.
83. Soldin S, Brugnara C, Wong E, eds. Pediatric Reference Ranges, 4th edn. AACC Press, 2003.
84. Honour J, Hormone reference ranges. In: Clayton B, Round J, eds. Clinical Biochemistry and the Sick Child, 2nd edn. Blackwell Scientific Publications, 1994: 540-1.